Autonomic dysfunction - postural hypotension
Description
- Sustained fall in BP within 3 minutes of standing: >=20 mmHg systolic, or >=10 mmHg diastolic
- Or >=30 systolic if supine hypertension is present
- Variants
- Initial orthostatic hypotension - transient fall >40 systolic within 15 s, resolves by 30 s; needs beat-to-beat monitoring, not a manual cuff
- Delayed orthostatic hypotension - beyond 3 min; often an early marker of degenerative autonomic failure
- Postprandial hypotension - within 2 h of a meal; common and under-recognised in the elderly
- Neurogenic OH - no compensatory rise in heart rate (HR rise <15 bpm, or a ratio of HR change to systolic BP change <0.5)
- Discriminator: does the pulse rise?
- Rises appropriately -> volume depletion, blood loss, drugs
- Does not rise -> neurogenic (autonomic failure), or beta-blockade, or a paced/denervated heart
Epidemiology
- ~5-10% of community-dwelling elderly; 20-30% over 75; up to 50% of nursing home residents
- Rare under 50 unless neurogenic or drug-induced
- Present in ~30-60% of Parkinson disease, and near-universal in multiple system atrophy and pure autonomic failure
- Independently predicts falls, fracture, cognitive decline, cardiovascular events and mortality
Aetiopathogenesis
Normal response to standing
- 500-1000 mL pools in the legs and splanchnic bed
- -> dec venous return -> dec cardiac output -> dec carotid/aortic baroreceptor firing
- -> baroreflex: inc sympathetic outflow, dec vagal tone
- -> inc HR (10-20 bpm) + peripheral vasoconstriction -> BP maintained
Why the elderly fail
- The primary mechanism in older people is impaired baroreceptor reflex sensitivity, reducing the compensatory heart rate and vasoconstrictor response to the fall in blood pressure on standing
- Compounded by
- Arterial stiffening -> less buffering
- Diastolic dysfunction -> steeply preload-dependent stroke volume
- Reduced thirst and renal sodium conservation -> chronic subclinical hypovolaemia
- Polypharmacy
Causes
A. Neurogenic - central
- Multiple system atrophy (severe early OH with relatively preserved cognition and poor levodopa response)
- Parkinson disease, dementia with Lewy bodies, pure autonomic failure
- Spinal cord lesion, brainstem stroke
B. Neurogenic - peripheral
- Diabetic autonomic neuropathy - the commonest peripheral cause
- Amyloidosis (AL and hereditary ATTR), Sjogren, paraneoplastic, HIV, B12 deficiency, chemotherapy (vincristine, platinum), Guillain-Barre, autoimmune autonomic ganglionopathy
C. Non-neurogenic
- Hypovolaemia - haemorrhage, dehydration, diuretics, adrenal insufficiency, diabetes insipidus
- Cardiac - aortic stenosis, HFpEF, arrhythmia, constrictive pericarditis
- Drugs - always the first thing to review
- Antihypertensives (esp. alpha-blockers, diuretics), nitrates, levodopa and dopamine agonists, TCAs, antipsychotics, SSRIs, opioids, PDE5 inhibitors, alcohol
- Deconditioning, prolonged bed rest, large varicose veins
Diagnosis
The measurement itself
- Supine for 5 minutes, then BP and HR at 1 and 3 minutes standing (standing, not sitting - sitting misses up to half of cases)
- Repeat in the morning and after a meal if the history is suggestive but the test is negative
- Calculate the HR response - it is the key discriminator and is almost always omitted
History
- Symptoms: light-headedness, "coat-hanger" neck and shoulder ache (highly specific for OH - suboccipital muscle ischaemia), visual greying, fatigue, cognitive slowing, syncope, falls
- Timing: morning, post-prandial, post-exertional, hot weather, after alcohol
- Full medication review including timing of doses
- Autonomic review of systems: constipation, urinary symptoms, erectile dysfunction, sweating change - their presence points to a generalised autonomic disorder
Examination
- Lying/standing BP, supine hypertension, hydration
- Neurological: parkinsonism, cerebellar signs, peripheral neuropathy, anhidrosis
- Cardiac: murmur, arrhythmia
Investigations
- FBE, UEC, glucose/HbA1c, B12, TSH, morning cortisol/short synacthen if indicated
- SPEP/free light chains - amyloid
- ECG; echo if a cardiac cause is suspected
- Tilt table testing if the diagnosis is uncertain or syncope is unexplained
- Formal autonomic testing (Valsalva ratio, heart rate variability, sweat testing) in specialist centres
- Supine and standing plasma noradrenaline: fails to rise on standing in neurogenic OH; low supine level suggests peripheral, normal suggests central
Management
Target symptoms and falls, not the number. Aim for standing systolic >90 mmHg.
A. Deprescribe first - the highest-yield step
- Review and withdraw or reduce antihypertensives, alpha-blockers, nitrates, TCAs, antipsychotics, diuretics
- If antihypertensives are still needed, dose at night and prefer agents with less orthostatic effect
B. Non-pharmacological - always before drugs
- Rise slowly and in stages; sit on the bed before standing
- Increase salt (up to 6-10 g/day) and fluid (2-2.5 L/day) unless heart failure or renal disease
- Rapid bolus of 500 mL cold water raises BP within 5-15 min for ~1 h - useful before rising or before a meal
- Physical counter-manoeuvres: leg crossing, squatting, toe-raises, tensing buttocks and abdomen
- Compression: abdominal binder is more effective than stockings (the splanchnic bed holds more blood than the legs); waist-high stockings if used
- Head-up tilt of the bed by 10-20 degrees at night - reduces nocturnal natriuresis and morning OH
- Small, low-carbohydrate, frequent meals; avoid alcohol and large hot meals
- Avoid straining, hot baths, prolonged standing
- Exercise: recumbent - swimming, rowing, cycling
C. Pharmacological - if symptoms persist
| Drug | Dose | Note |
|---|---|---|
| Fludrocortisone | 0.1-0.2 mg daily | Volume expansion. Monitor K+, weight, oedema; worsens supine hypertension |
| Midodrine | 2.5-10 mg tds | Alpha-1 agonist. Last dose >=4 h before bed - supine hypertension. Scalp tingling, urinary retention |
| Droxidopa | Not available in Australia | |
| Pyridostigmine | 30-60 mg tds | Modest; does not worsen supine hypertension - useful when it coexists |
| Desmopressin | low dose | Nocturnal polyuria; monitor sodium |
| Octreotide | Postprandial hypotension |
D. Supine hypertension - the therapeutic dilemma
- Present in ~50% of neurogenic OH; treating OH worsens it
- Never lie flat during the day; sleep head-up
- Short-acting agent at bedtime if severe (nitrate patch removed on waking, losartan, or captopril)
- Accept moderate supine hypertension in exchange for symptom control and fall prevention - falls kill sooner than nocturnal BP
Associations
- Falls, fractures, syncope
- Parkinson disease, multiple system atrophy, dementia with Lewy bodies, pure autonomic failure
- Diabetic and amyloid autonomic neuropathy
- Supine hypertension (~50% of neurogenic cases)
- Cognitive impairment and dementia - repeated cerebral hypoperfusion
- Adrenal insufficiency, anaemia, dehydration
- Polypharmacy and frailty
Natural history & complications
- Independently associated with increased all-cause mortality, cardiovascular events, stroke, falls and incident dementia - it is not a benign nuisance
- Neurogenic OH is progressive and reflects the underlying degenerative process
- Drug- and volume-related OH is often fully reversible
- In multiple system atrophy, severe early OH is a defining feature and a poor prognostic marker
Monitor
- Lying/standing BP at every review, including after any drug change
- Falls history, weight, electrolytes (fludrocortisone)
- Supine BP at night if on midodrine or fludrocortisone
🔒
6 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access